0001140361-18-008870.txt : 20180216
0001140361-18-008870.hdr.sgml : 20180216
20180216200124
ACCESSION NUMBER: 0001140361-18-008870
CONFORMED SUBMISSION TYPE: 4
PUBLIC DOCUMENT COUNT: 1
CONFORMED PERIOD OF REPORT: 20180214
FILED AS OF DATE: 20180216
DATE AS OF CHANGE: 20180216
REPORTING-OWNER:
OWNER DATA:
COMPANY CONFORMED NAME: MAZELSKY JAY
CENTRAL INDEX KEY: 0001556270
FILING VALUES:
FORM TYPE: 4
SEC ACT: 1934 Act
SEC FILE NUMBER: 000-19271
FILM NUMBER: 18622778
MAIL ADDRESS:
STREET 1: ONE IDEXX DRIVE
CITY: WESTBROOK
STATE: ME
ZIP: 04092
ISSUER:
COMPANY DATA:
COMPANY CONFORMED NAME: IDEXX LABORATORIES INC /DE
CENTRAL INDEX KEY: 0000874716
STANDARD INDUSTRIAL CLASSIFICATION: IN VITRO & IN VIVO DIAGNOSTIC SUBSTANCES [2835]
IRS NUMBER: 010393723
STATE OF INCORPORATION: DE
FISCAL YEAR END: 1231
BUSINESS ADDRESS:
STREET 1: ONE IDEXX DRIVE
CITY: WESTBROOK
STATE: ME
ZIP: 04092-2041
BUSINESS PHONE: 2075560300
MAIL ADDRESS:
STREET 1: ONE IDEXX DRIVE
CITY: WESTBROOK
STATE: ME
ZIP: 04092-2041
FORMER COMPANY:
FORMER CONFORMED NAME: IDEXX CORP / DE
DATE OF NAME CHANGE: 19600201
4
1
doc1.xml
FORM 4
X0306
4
2018-02-14
0
0000874716
IDEXX LABORATORIES INC /DE
IDXX
0001556270
MAZELSKY JAY
ONE IDEXX DRIVE
WESTBROOK
ME
04092
0
1
0
0
Executive Vice President
Common Stock
2018-02-14
4
M
0
544
0
A
19467
D
Common Stock
2018-02-14
4
M
0
403
0
A
19870
D
Common Stock
2018-02-14
4
M
0
472
0
A
20342
D
Common Stock
2018-02-14
4
M
0
737
0
A
21079
D
Common Stock
2018-02-14
4
M
0
459
0
A
21538
D
Common Stock
2018-02-14
4
F
0
778
178.26
D
20760
D
Non-Qualified Stock Option (right-to-buy)
178.26
2018-02-14
4
A
0
25140
A
2028-02-13
Common Stock
25140
25140
D
Incentive Stock Option (right-to-buy)
178.26
2018-02-14
4
A
0
560
A
2028-02-13
Common Stock
560
560
D
Restricted Stock Unit
2018-02-14
4
A
0
2524
A
Common Stock
2524
11492
D
Restricted Stock Unit
2018-02-14
4
M
0
544
D
Common Stock
544
10948
D
Restricted Stock Unit
2018-02-14
4
M
0
403
D
Common Stock
403
10545
D
Restricted Stock Unit
2018-02-14
4
M
0
472
D
Common Stock
472
10073
D
Restricted Stock Unit
2018-02-14
4
M
0
737
D
Common Stock
737
9336
D
Restricted Stock Unit
2018-02-14
4
M
0
459
D
Common Stock
459
8877
D
Includes 39 shares acquired under the IDEXX Laboratories, Inc. Employee Stock Purchase Plan on December 29, 2017.
Closing price of Issuer's common stock on the NASDAQ market on February 14, 2018.
Grant of option to buy shares of Issuer common stock that becomes exercisable in five annual installments beginning February 14, 2019.
Grant of option to buy shares of Issuer common stock that becomes exercisable on the fifth anniversary of the date of grant.
Each restricted stock unit ("RSU") represents a contingent right to receive one share of Issuer common stock. This RSU grant vests in five equal annual installments, beginning February 14, 2019.
Each RSU represents a contingent right to receive one share of Issuer common stock. This RSU grant vests in five equal annual installments, beginning February 14, 2014. The number of RSUs have been adjusted to reflect the 2-for-1 stock split of Issuer common stock that occurred on June 15, 2015 (the "Stock Split").
Each RSU represents a contingent right to receive one share of Issuer common stock. This RSU grant vests in five equal annual installments, beginning February 14, 2015 and has been adjusted to reflect the Stock Split.
Each RSU represents a contingent right to receive one share of Issuer common stock. This RSU grant vests in five equal annual installments, beginning February 14, 2016 and has been adjusted to reflect the Stock Split.
Each RSU represents a contingent right to receive one share of Issuer common stock. This RSU grant vests in five equal annual installments, beginning February 14, 2017.
Each RSU represents a contingent right to receive one share of Issuer common stock. This RSU grant vests in five equal annual installments, beginning February 14, 2018.
No applicable.
/s/ Lily J. Lu, Attorney-in-Fact for Jay Mazelsky
2018-02-16